Thesis Abstract

Abstract
Epigenetic modifications play a crucial role in cancer development and progression by regulating gene expression without altering the underlying DNA sequence. This thesis explores the intricate relationship between epigenetic modifications and cancer, focusing on how these modifications contribute to tumorigenesis, metastasis, and therapy resistance. The study investigates various epigenetic mechanisms, including DNA methylation, histone modifications, and non-coding RNAs, and their impact on cancer pathogenesis. Chapter One provides an introduction to the topic, discussing the background of the study, the problem statement, objectives, limitations, scope, significance, structure of the thesis, and key definitions of terms. The literature review in Chapter Two encompasses ten critical areas, highlighting current research on epigenetic modifications in different cancer types and their clinical implications. Chapter Three outlines the research methodology, detailing the study design, sample collection and analysis techniques, data interpretation methods, ethical considerations, and potential limitations. The results of the study are extensively discussed in Chapter Four, emphasizing the role of specific epigenetic modifications in cancer progression and their potential as therapeutic targets. The chapter also explores the interplay between epigenetic alterations and other molecular pathways in cancer cells. In the concluding Chapter Five, the findings are summarized, and their implications for cancer research and treatment are discussed. The study underscores the importance of understanding epigenetic modifications in cancer biology and highlights the potential for developing targeted therapies based on these mechanisms. Overall, this thesis contributes to the growing body of knowledge on the role of epigenetics in cancer development and progression, shedding light on novel avenues for improving cancer diagnosis and treatment strategies. Keywords Epigenetic Modifications, Cancer Development, Cancer Progression, Tumorigenesis, Metastasis, Therapy Resistance, DNA Methylation, Histone Modifications, Non-coding RNAs, Therapeutic Targets.

Thesis Overview